A retrospective study comparing Somatostatin Analogs in the Treatment of Advanced Gastroenteropancreatic Neuroendocrine Tumors
Latest Information Update: 21 Mar 2022
At a glance
- Drugs Lanreotide (Primary) ; Octreotide (Primary)
- Indications Gastric cancer; Gastro-enteropancreatic neuroendocrine tumour; Pancreatic cancer
- Focus Therapeutic Use
Most Recent Events
- 21 Mar 2022 New trial record